{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:27:30Z","timestamp":1766852850473,"version":"3.48.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100012021","name":"Iran University of Medical Sciences","doi-asserted-by":"crossref","award":["1400-2-22-21687"],"award-info":[{"award-number":["1400-2-22-21687"]}],"id":[{"id":"10.13039\/100012021","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10431-4","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T10:34:11Z","timestamp":1744972451000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["High de novo mutation rate in Iranian NF2-related schwannomatosis patients with a report of a novel NF2 mutation"],"prefix":"10.1007","volume":"52","author":[{"given":"Mohammad Amin","family":"Ghalavand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9107-4309","authenticated-orcid":false,"given":"Alimohamad","family":"Asghari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4611-8859","authenticated-orcid":false,"given":"Amin","family":"Jahanbakhshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5221-1844","authenticated-orcid":false,"given":"Khalil Ghasemi","family":"Falavarjani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7384-6400","authenticated-orcid":false,"given":"Ali","family":"Eftekharian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6303-1750","authenticated-orcid":false,"given":"Mohammad","family":"Farhadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hessamaldin","family":"Emamdjomeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5508-7903","authenticated-orcid":false,"given":"Masoud","family":"Garshasbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2800-4199","authenticated-orcid":false,"given":"Masoumeh","family":"Falah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,18]]},"reference":[{"unstructured":"Evans DG, Wen P. NF2-related schwannomatosis (formerly neurofibromatosis type 2). UpToDate, Waltham, MA (last updated: Oct 28, 2022).","key":"10431_CR1"},{"issue":"2","key":"10431_CR2","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ajmg.a.33139","volume":"152a","author":"DG Evans","year":"2010","unstructured":"Evans DG, Howard E, Giblin C, Clancy T, Spencer H, Huson SM et al (2010) Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A. 152a(2):327\u201332. https:\/\/doi.org\/10.1002\/ajmg.a.33139","journal-title":"Am J Med Genet A."},{"issue":"16","key":"10431_CR3","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1016\/j.febslet.2014.04.001","volume":"588","author":"J Cooper","year":"2014","unstructured":"Cooper J, Giancotti FG (2014) Molecular insights into NF2\/Merlin tumor suppressor function. FEBS Lett 588(16):2743\u20132752. https:\/\/doi.org\/10.1016\/j.febslet.2014.04.001","journal-title":"FEBS Lett"},{"issue":"1","key":"10431_CR4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12935-023-02940-8","volume":"23","author":"MA Ghalavand","year":"2023","unstructured":"Ghalavand MA, Asghari A, Farhadi M, Taghizadeh-Hesary F, Garshasbi M, Falah M (2023) The genetic landscape and possible therapeutics of neurofibromatosis type 2. Cancer Cell Int 23(1):99. https:\/\/doi.org\/10.1186\/s12935-023-02940-8","journal-title":"Cancer Cell Int"},{"issue":"10","key":"10431_CR5","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1136\/jmedgenet-2017-104519","volume":"54","author":"D Halliday","year":"2017","unstructured":"Halliday D, Emmanouil B, Pretorius P, MacKeith S, Painter S, Tomkins H et al (2017) Genetic severity score predicts clinical phenotype in NF2. J Med Genet 54(10):657\u2013664. https:\/\/doi.org\/10.1136\/jmedgenet-2017-104519","journal-title":"J Med Genet"},{"issue":"1","key":"10431_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41436-019-0598-7","volume":"22","author":"DG Evans","year":"2020","unstructured":"Evans DG, Hartley CL, Smith PT, King AT, Bowers NL, Tobi S et al (2020) Incidence of mosaicism in 1055 de novo NF2 cases: much higher than previous estimates with high utility of next-generation sequencing. Genet Med 22(1):53\u201359. https:\/\/doi.org\/10.1038\/s41436-019-0598-7","journal-title":"Genet Med"},{"key":"10431_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2020.106053","volume":"197","author":"AB Koo","year":"2020","unstructured":"Koo AB, Yeung JT, Freedman IG, Lee JH, Ahmed OM, Ma AK et al (2020) Clinical and economic burden of neurofibromatosis type 2 in the United States. Clin Neurol Neurosurg 197:106053. https:\/\/doi.org\/10.1016\/j.clineuro.2020.106053","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"10431_CR8","doi-asserted-by":"publisher","first-page":"6934","DOI":"10.1038\/s41598-024-57401-7","volume":"14","author":"A Freier","year":"2024","unstructured":"Freier A, Lawson McLean AC, Loeschner D, Rosahl SK, Kruse J (2024) The impact of mental health on health-related quality of life in patients with NF2-related Schwannomatosis. Sci Rep 14(1):6934. https:\/\/doi.org\/10.1038\/s41598-024-57401-7","journal-title":"Sci Rep"},{"issue":"5","key":"10431_CR9","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1177\/0194599815573223","volume":"153","author":"H Mahboubi","year":"2015","unstructured":"Mahboubi H, Maducdoc MM, Yau AY, Ziai K, Ghavami Y, Badran KW et al (2015) Vestibular Schwannoma excision in sporadic versus neurofibromatosis type 2 populations. Otolaryngol-Head Neck Surg 153(5):822\u201331. https:\/\/doi.org\/10.1177\/0194599815573223","journal-title":"Otolaryngol-Head Neck Surg"},{"issue":"9","key":"10431_CR10","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/j.gim.2022.05.007","volume":"24","author":"SR Plotkin","year":"2022","unstructured":"Plotkin SR, Messiaen L, Legius E, Pancza P, Avery RA, Blakeley JO et al (2022) Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: an international consensus recommendation. Genet Med 24(9):1967\u20131977. https:\/\/doi.org\/10.1016\/j.gim.2022.05.007","journal-title":"Genet Med"},{"issue":"1","key":"10431_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15513815.2019.1627625","volume":"39","author":"M Falah","year":"2020","unstructured":"Falah M, Houshmand M, Balali M, Asghari A, Bagher Z, Alizadeh R et al (2020) Role of GJB2 and GJB6 in Iranian nonsyndromic hearing impairment: from molecular analysis to literature reviews. Fetal Pediatr Pathol 39(1):1\u201312. https:\/\/doi.org\/10.1080\/15513815.2019.1627625","journal-title":"Fetal Pediatr Pathol"},{"doi-asserted-by":"publisher","unstructured":"Falah M, Houshmand M, Akbaroghli S, Mahmodian S, Ghavami Y, Farhadi M (2011) Profile of Iranian GJB2 mutations in young population with novel mutation. Iranian J Basic Med Sci. https:\/\/doi.org\/10.22038\/ijbms.2011.4992","key":"10431_CR12","DOI":"10.22038\/ijbms.2011.4992"},{"issue":"1","key":"10431_CR13","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12920-023-01682-w","volume":"16","author":"A Daneshi","year":"2023","unstructured":"Daneshi A, Garshasbi M, Farhadi M, Falavarjani KG, Vafaee-Shahi M, Almadani N et al (2023) Genetic insights into PHARC syndrome: identification of a novel frameshift mutation in ABHD12. BMC Med Genomics 16(1):235. https:\/\/doi.org\/10.1186\/s12920-023-01682-w","journal-title":"BMC Med Genomics"},{"issue":"1","key":"10431_CR14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12920-022-01287-9","volume":"15","author":"S Rayat","year":"2022","unstructured":"Rayat S, Farhadi M, Emamdjomeh H, Morovvati S, Falah M (2022) Analysis of TMIE gene mutations including the first large deletion of exon 1 with autosomal recessive non-syndromic deafness. BMC Med Genomics 15(1):133. https:\/\/doi.org\/10.1186\/s12920-022-01287-9","journal-title":"BMC Med Genomics"},{"issue":"8","key":"10431_CR15","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","volume":"37","author":"D Kim","year":"2019","unstructured":"Kim D, Paggi JM, Park C, Bennett C, Salzberg SL (2019) Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol 37(8):907\u2013915. https:\/\/doi.org\/10.1038\/s41587-019-0201-4","journal-title":"Nat Biotechnol"},{"issue":"D1","key":"10431_CR16","doi-asserted-by":"publisher","first-page":"D862","DOI":"10.1093\/nar\/gkv1222","volume":"44","author":"MJ Landrum","year":"2016","unstructured":"Landrum MJ, Lee JM, Benson M, Brown G, Chao C, Chitipiralla S et al (2016) ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res 44(D1):D862\u2013D868. https:\/\/doi.org\/10.1093\/nar\/gkv1222","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10431_CR17","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/humu.10212","volume":"21","author":"PD Stenson","year":"2003","unstructured":"Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NS et al (2003) Human gene mutation database (HGMD): 2003 update. Hum Mutat 21(6):577\u2013581. https:\/\/doi.org\/10.1002\/humu.10212","journal-title":"Hum Mutat"},{"issue":"16","key":"10431_CR18","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1093\/bioinformatics\/btv195","volume":"31","author":"Y Choi","year":"2015","unstructured":"Choi Y, Chan AP (2015) PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics 31(16):2745\u20132747. https:\/\/doi.org\/10.1093\/bioinformatics\/btv195","journal-title":"Bioinformatics"},{"issue":"4","key":"10431_CR19","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nmeth.2890","volume":"11","author":"JM Schwarz","year":"2014","unstructured":"Schwarz JM, Cooper DN, Schuelke M, Seelow D (2014) MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods 11(4):361\u2013362. https:\/\/doi.org\/10.1038\/nmeth.2890","journal-title":"Nat Methods"},{"issue":"1","key":"10431_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nprot.2015.123","volume":"11","author":"R Vaser","year":"2016","unstructured":"Vaser R, Adusumalli S, Leng SN, Sikic M, Ng PC (2016) SIFT missense predictions for genomes. Nat Protoc 11(1):1\u20139. https:\/\/doi.org\/10.1038\/nprot.2015.123","journal-title":"Nat Protoc"},{"issue":"4","key":"10431_CR21","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P et al (2010) A method and server for predicting damaging missense mutations. Nat Methods 7(4):248\u2013249. https:\/\/doi.org\/10.1038\/nmeth0410-248","journal-title":"Nat Methods"},{"issue":"6","key":"10431_CR22","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nprot.2015.053","volume":"10","author":"LA Kelley","year":"2015","unstructured":"Kelley LA, Mezulis S, Yates CM, Wass MN, Sternberg MJ (2015) The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc 10(6):845\u2013858. https:\/\/doi.org\/10.1038\/nprot.2015.053","journal-title":"Nat Protoc"},{"key":"10431_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/20.suppl.2019","author":"A Bairoch","year":"1992","unstructured":"Bairoch A, Boeckmann B (1992) The SWISS-PROT protein sequence data bank. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/20.suppl.2019","journal-title":"Nucleic Acids Res"},{"issue":"15","key":"10431_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks596","volume":"40","author":"A Untergasser","year":"2012","unstructured":"Untergasser A, Cutcutache I, Koressaar T, Ye J, Faircloth BC, Remm M et al (2012) Primer3\u2013new capabilities and interfaces. Nucleic Acids Res 40(15):e115. https:\/\/doi.org\/10.1093\/nar\/gks596","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10431_CR25","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1007\/s11845-021-02736-7","volume":"191","author":"M Vafaee-Shahi","year":"2022","unstructured":"Vafaee-Shahi M, Farhadi M, Razmara E, Morovvati S, Ghasemi S, Abedini SS et al (2022) Novel phenotype and genotype spectrum of NARS2 and literature review of previous mutations. Ir J Med Sci 191(4):1877\u20131890. https:\/\/doi.org\/10.1007\/s11845-021-02736-7","journal-title":"Ir J Med Sci"},{"issue":"6","key":"10431_CR26","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/humu.22981","volume":"37","author":"JT den Dunnen","year":"2016","unstructured":"den Dunnen JT, Dalgleish R, Maglott DR, Hart RK, Greenblatt MS, McGowan-Jordan J et al (2016) HGVS recommendations for the description of sequence variants: 2016 update. Hum Mutat 37(6):564\u2013569. https:\/\/doi.org\/10.1002\/humu.22981","journal-title":"Hum Mutat"},{"issue":"3","key":"10431_CR27","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.jmoldx.2016.01.002","volume":"18","author":"L Qin","year":"2016","unstructured":"Qin L, Wang J, Tian X, Yu H, Truong C, Mitchell JJ et al (2016) Detection and quantification of mosaic mutations in disease genes by next-generation sequencing. J Mol Diagn: JMD 18(3):446\u2013453. https:\/\/doi.org\/10.1016\/j.jmoldx.2016.01.002","journal-title":"J Mol Diagn: JMD"},{"issue":"5","key":"10431_CR28","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/cge.14310","volume":"103","author":"D Halliday","year":"2023","unstructured":"Halliday D, Emmanouil B, Evans DGR (2023) Updated protocol for genetic testing, screening and clinical management of individuals at risk of NF2-related schwannomatosis. Clin Genet 103(5):540\u2013552. https:\/\/doi.org\/10.1111\/cge.14310","journal-title":"Clin Genet"},{"issue":"1","key":"10431_CR29","doi-asserted-by":"publisher","first-page":"6595","DOI":"10.1038\/s41598-023-33812-w","volume":"13","author":"N Oishi","year":"2023","unstructured":"Oishi N, Noguchi M, Fujioka M, Nara K, Wasano K, Mutai H et al (2023) Correlation between genotype and phenotype with special attention to hearing in 14 Japanese cases of NF2-related schwannomatosis. Sci Rep 13(1):6595. https:\/\/doi.org\/10.1038\/s41598-023-33812-w","journal-title":"Sci Rep"},{"key":"10431_CR30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1750-1172-4-16","volume":"4","author":"DG Evans","year":"2009","unstructured":"Evans DG (2009) Neurofibromatosis type 2 (NF2): a clinical and molecular review. Orphanet J Rare Dis 4:16. https:\/\/doi.org\/10.1186\/1750-1172-4-16","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"10431_CR31","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/hmg\/10.3.271","volume":"10","author":"CE Bruder","year":"2001","unstructured":"Bruder CE, Hirvel\u00e4 C, Tapia-Paez I, Fransson I, Segraves R, Hamilton G et al (2001) High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH. Hum Mol Genet 10(3):271\u2013282. https:\/\/doi.org\/10.1093\/hmg\/10.3.271","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10431_CR32","doi-asserted-by":"publisher","first-page":"9543","DOI":"10.1038\/s41598-022-13580-9","volume":"12","author":"Y Teranishi","year":"2022","unstructured":"Teranishi Y, Miyawaki S, Nakatomi H, Ohara K, Hongo H, Dofuku S et al (2022) Early prediction of functional prognosis in neurofibromatosis type 2 patients based on genotype-phenotype correlation with targeted deep sequencing. Sci Rep 12(1):9543. https:\/\/doi.org\/10.1038\/s41598-022-13580-9","journal-title":"Sci Rep"},{"issue":"11","key":"10431_CR33","doi-asserted-by":"publisher","first-page":"105275","DOI":"10.1016\/j.isci.2022.105275","volume":"25","author":"Z Jia","year":"2022","unstructured":"Jia Z, Yang S, Li M, Lei Z, Ding X, Fan M et al (2022) A novel NF2 splicing mutant causes neurofibromatosis type 2 via liquid-liquid phase separation with large tumor suppressor and Hippo pathway. iScience. 25(11):105275. https:\/\/doi.org\/10.1016\/j.isci.2022.105275","journal-title":"iScience."},{"key":"10431_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/jmg-2024-110065","author":"C Forde","year":"2024","unstructured":"Forde C, Smith MJ, Burghel GJ, Bowers N, Roberts N, Lavin T et al (2024) NF2-related schwannomatosis and other schwannomatosis: an updated genetic and epidemiological study. J Med Genet. https:\/\/doi.org\/10.1136\/jmg-2024-110065","journal-title":"J Med Genet"},{"issue":"4","key":"10431_CR35","doi-asserted-by":"publisher","first-page":"571","DOI":"10.18240\/ijo.2019.04.07","volume":"12","author":"A Supartoto","year":"2019","unstructured":"Supartoto A, Mahayana IT, Heriyanto DS, Sasongko MB, Respatika HD, Sakti DH et al (2019) Neurofibromatosis type 2 gene mutation and progesterone receptor messenger RNA expression in the pathogenesis of sporadic orbitocranial meningioma. Int J Ophthalmol 12(4):571\u2013576. https:\/\/doi.org\/10.18240\/ijo.2019.04.07","journal-title":"Int J Ophthalmol"},{"issue":"5","key":"10431_CR36","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1002\/ijc.31399","volume":"143","author":"M Suzuki","year":"2018","unstructured":"Suzuki M, Kushner BH, Kramer K, Basu EM, Roberts SS, Hammond WJ et al (2018) Treatment and outcome of adult-onset neuroblastoma. Int J Cancer 143(5):1249\u20131258. https:\/\/doi.org\/10.1002\/ijc.31399","journal-title":"Int J Cancer"},{"issue":"4","key":"10431_CR37","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1089\/gte.2004.8.368","volume":"8","author":"AJ Wallace","year":"2004","unstructured":"Wallace AJ, Watson CJ, Oward E, Evans DG, Elles RG (2004) Mutation scanning of the NF2 gene: an improved service based on meta-PCR\/sequencing, dosage analysis, and loss of heterozygosity analysis. Genet Test 8(4):368\u2013380. https:\/\/doi.org\/10.1089\/gte.2004.8.368","journal-title":"Genet Test"},{"issue":"2","key":"10431_CR38","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/gcc.2870120206","volume":"12","author":"P M\u00e9rel","year":"1995","unstructured":"M\u00e9rel P, Hoang-Xuan K, Sanson M, Bijlsma E, Rouleau G, Laurent-Puig P et al (1995) Screening for germ-line mutations in the NF2 gene. Genes Chromosom Cancer 12(2):117\u2013127. https:\/\/doi.org\/10.1002\/gcc.2870120206","journal-title":"Genes Chromosom Cancer"},{"issue":"2","key":"10431_CR39","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/s0002-9440(10)65158-9","volume":"155","author":"C Ebert","year":"1999","unstructured":"Ebert C, von Haken M, Meyer-Puttlitz B, Wiestler OD, Reifenberger G, Pietsch T et al (1999) Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas. Am J Pathol 155(2):627\u201332. https:\/\/doi.org\/10.1016\/s0002-9440(10)65158-9","journal-title":"Am J Pathol"},{"issue":"8","key":"10431_CR40","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/gcc.20876","volume":"50","author":"JR Ellis Jr","year":"2011","unstructured":"Ellis JR Jr, Heinrich B, Mautner VF, Kluwe L (2011) Effects of splicing mutations on NF2-transcripts: transcript analysis and information theoretic predictions. Genes Chromosom Cancer 50(8):571\u2013584. https:\/\/doi.org\/10.1002\/gcc.20876","journal-title":"Genes Chromosom Cancer"},{"issue":"6","key":"10431_CR41","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1136\/jmg.35.6.450","volume":"35","author":"DG Evans","year":"1998","unstructured":"Evans DG, Trueman L, Wallace A, Collins S, Strachan T (1998) Genotype\/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations. J Med Genet 35(6):450\u2013455. https:\/\/doi.org\/10.1136\/jmg.35.6.450","journal-title":"J Med Genet"},{"issue":"7818","key":"10431_CR42","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41586-020-2493-4","volume":"583","author":"JE Moore","year":"2020","unstructured":"Moore JE, Purcaro MJ, Pratt HE, Epstein CB, Shoresh N, Adrian J et al (2020) Expanded encyclopaedias of DNA elements in the human and mouse genomes. Nature 583(7818):699\u2013710. https:\/\/doi.org\/10.1038\/s41586-020-2493-4","journal-title":"Nature"},{"issue":"4","key":"10431_CR43","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/gcc.20138","volume":"42","author":"L Kluwe","year":"2005","unstructured":"Kluwe L, Nygren AO, Errami A, Heinrich B, Matthies C, Tatagiba M et al (2005) Screening for large mutations of the NF2 gene. Genes Chromosom Cancer 42(4):384\u2013391. https:\/\/doi.org\/10.1002\/gcc.20138","journal-title":"Genes Chromosom Cancer"},{"issue":"4","key":"10431_CR44","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/WNO.0b013e3182726b49","volume":"32","author":"VJ Barrett","year":"2012","unstructured":"Barrett VJ, Tan MH, Elston JS (2012) Recurrent third nerve palsy as the presenting feature of neurofibromatosis 2. J Neuro-ophthalmol: Off J North Am Neuro-Ophthalmol Soc 32(4):329\u2013331. https:\/\/doi.org\/10.1097\/WNO.0b013e3182726b49","journal-title":"J Neuro-ophthalmol: Off J North Am Neuro-Ophthalmol Soc"},{"issue":"1","key":"10431_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/humu.20393","volume":"28","author":"I Ahronowitz","year":"2007","unstructured":"Ahronowitz I, Xin W, Kiely R, Sims K, MacCollin M, Nunes FP (2007) Mutational spectrum of the NF2 gene: a meta-analysis of 12 years of research and diagnostic laboratory findings. Hum Mutat 28(1):1\u201312. https:\/\/doi.org\/10.1002\/humu.20393","journal-title":"Hum Mutat"},{"issue":"9","key":"10431_CR46","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1136\/jmg-2022-108960","volume":"60","author":"DG Evans","year":"2023","unstructured":"Evans DG, Burghel GJ, Smith MJ (2023) Differential rates of germline heterozygote and mosaic variants in NF2 may show varying propensity for meiotic or mitotic mutation. J Med Genet 60(9):838\u2013841. https:\/\/doi.org\/10.1136\/jmg-2022-108960","journal-title":"J Med Genet"},{"issue":"304","key":"10431_CR47","first-page":"603","volume":"84","author":"DG Evans","year":"1992","unstructured":"Evans DG, Huson SM, Donnai D, Neary W, Blair V, Newton V et al (1992) A clinical study of type 2 neurofibromatosis. Q J Med 84(304):603\u2013618","journal-title":"Q J Med"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10431-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10431-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10431-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:24:33Z","timestamp":1766852673000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10431-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,18]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10431"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10431-4","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2025,4,18]]},"assertion":[{"value":"23 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The research was carried out in accordance with the principles outlined in the Declaration of Helsinki and was approved by the Iran University of Medical Sciences (Approval number: IR. IUMS.REC.1400.1127) in Tehran, Iran.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Participants and\/or their legal guardians (s) provided informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Written informed consent was obtained from the legal guardians to share clinical facts and photos.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"402"}}